Prospects for B-cell-targeted therapy in autoimmune disease.
about
Adalimumab for the treatment of rheumatoid arthritisRegulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosisHow does B cell depletion therapy work, and how can it be improved?Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndromeFunctional identification of pathogenic autoantibody responses in patients with multiple sclerosis.B-cell selection and the development of autoantibodies.B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.Epratuzumab in the therapy of oncological and immunological diseases.Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in miceB-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.Targeting lentiviral vectors to antigen-specific immunoglobulins.Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity.Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis.Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.Targeted gene therapy of autoimmune diseases: advances and prospects.[A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy].Anti-CD20 Cell Therapies in Multiple Sclerosis-A Fixed Dosing Schedule for Ocrelizumab is Overkill.The molecular basis of immune regulation in autoimmunity.
P2860
Q28282655-05BEB902-0ADA-44C0-A8C2-F4C40A46E710Q34831296-DA58F83F-2EB5-47EE-8246-1B3503A5631FQ35222002-0A2B1485-63E0-484A-8EA7-12F46E70FAB4Q35579475-C1B49A0F-DD49-4610-B28C-3C327A20F54FQ35907701-026C89DC-0F51-4DEF-8D1A-C09131569FDAQ35986699-5E7CE576-E664-42D9-B2D9-5C7052E8459EQ36504635-6A92BBEA-A82C-4383-8604-4FB2F1A1B79BQ36577391-8324B85B-5904-4565-A091-44C005D1ED83Q36636619-5AFA7D16-5FC9-428F-9D23-629327000DADQ36693339-B789CBB5-342F-4CC0-AD05-0864652B39DAQ36897408-2E725F24-8CDD-4494-A7DD-C25DB593A993Q37008067-32282109-2778-4B7A-BAF5-683FFFD62359Q40059466-B735EC9F-87DA-4A23-9849-A0976C55C453Q40119794-77DD4439-EF57-4DB5-9362-E70A179C1F27Q42392488-19071C36-A6B0-4F27-BE9B-84370219401CQ42955604-D090E7F3-ADC7-4643-8E31-310F6A2AEADDQ45859107-D15F35C6-9FDC-4886-BA74-6A82614E244DQ46986955-89EC9A7E-AE84-427B-AE19-04858C15FC3CQ48519153-F9DC6E80-CBFE-49CA-867E-9C1084E01516Q50158327-619E2F97-C80F-44CA-813E-F6E3F77E4F89
P2860
Prospects for B-cell-targeted therapy in autoimmune disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prospects for B-cell-targeted therapy in autoimmune disease.
@ast
Prospects for B-cell-targeted therapy in autoimmune disease.
@en
type
label
Prospects for B-cell-targeted therapy in autoimmune disease.
@ast
Prospects for B-cell-targeted therapy in autoimmune disease.
@en
prefLabel
Prospects for B-cell-targeted therapy in autoimmune disease.
@ast
Prospects for B-cell-targeted therapy in autoimmune disease.
@en
P2860
P356
P1433
P1476
Prospects for B-cell-targeted therapy in autoimmune disease.
@en
P2093
Cambridge G
Edwards JC
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEH446
P577
2004-10-27T00:00:00Z